Related Experiment Video
Updated: Jul 15, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Early cardiac involvement in children carrying the A3243G mtDNA mutation
S B Wortmann1, R J Rodenburg, A P Backx
1Department of Pediatrics, Radboud University Nijmegen Medical Centre, Nijmegen Centre for Mitochondrial Disorders, Nijmegen, The Netherlands.
Insights
The mitochondrial A3243G mutation presents variably in children, often with non-specific symptoms and early cardiac issues. Early cardiac screening is vital, as this mutation may be underdiagnosed and linked to unexplained deaths.
Area of Science:
- Genetics
- Pediatrics
- Cardiology
Background:
- The mitochondrial A3243G mutation has a variable phenotypic spectrum, especially in children.
- Pediatric presentation differs from adult MELAS syndrome, often lacking typical encephalopathy or psychomotor regression.
Purpose of the Study:
- To describe the clinical presentation and cardiac involvement in children with the A3243G mtDNA mutation.
- To highlight the potential underdiagnosis of this mutation in pediatric populations.
Main Methods:
- Retrospective analysis of six children with the A3243G mtDNA mutation (heteroplasmy >50% in muscle).
- Clinical data collection including age at diagnosis, symptoms, and cardiac assessments.
Main Results:
- Age at diagnosis ranged from 2 weeks to 14.5 years.
- Non-specific symptoms included muscle weakness, developmental delay, and epilepsy.
- Five of six children showed presymptomatic cardiac involvement (cardiomyopathy, hypertrophy, rhythm disturbances).
- Two patients experienced early mortality.
Conclusions:
- The A3243G mutation may be underdiagnosed, potentially leading to unexplained cardiac deaths.
- Recommend regular ECGs and echocardiography for all children with the A3243G mtDNA mutation, regardless of cardiac symptoms.
Unlabelled:
The phenotypic spectrum of the mitochondrial A3243G DKA mutation is highly variable, particularly when occuring in childhood. In contrast to the classical presentation in adulthood (MELAS syndrome; mitochondria! myopathy, encephalopathy, lactic acidosis and stroke-like episodes) children show a different pattern of symptoms, often without the typical encephalopathy or psychomotor regression. We present six children carrying the A3243G mtDNA mutation with a heteroplasmy above 50 % in muscle tissue. The age of diagnosis ranged from 2 weeks up to 14.5 years. The clinical presentation was rather non-specific including muscle weakness, developmental delay and epilepsy. In this small pediatric group we detected presymptomatic cardiac involvement in five out of six children already at an early stage of disease. The cardiac pathology included cardiomyopathy and biventricular hypertrophy with rhythm disturbances (for example long QT-syndrome). The observed cardiac changes do not always increase the risk of cardiac deterioration; however, two of our patients died early on.
Conclusion:
We hypothesize that the A3243G mutation might be underdiagnosed, as patients could suffer from an unexplained cardiac death before the diagnosis is made. We advise performing regular repeated ECGs and echocardiography in all children carrying a A3243G mtDNA mutation independently from the presence of cardiac symptoms.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Animal Mitochondrial Genetics
